The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.
People undergoing hemodialysis treatment for kidney failure often experience chronic pain related to their condition, but it ...
Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...
Recent developments, however, suggest that strategies to treat pain are starting to match its complexity with a new sophistication. The management of chronic pain in general is now being broadly ...
A massive stride has been made in the pain medication industry. The U.S. Food and Drug Administration (FDA) announced Thursday its approval of a non-opioid treatment for moderate to severe acute pain ...